Home › NDC Lookup › RxCUI directory › RxCUI 2569283

Hydroxychloroquine sulfate 300 MG Oral Tablet — RxCUI 2569283

RxNorm drug concept · Semantic clinical drug
RxCUI 2569283 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 20 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2569283
Official nameHydroxychloroquine sulfate 300 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped11
Package NDCs mapped20
Reported Medicaid activity (SDUD)143,633 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hydroxychloroquine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It has two main uses. First, it treats and helps prevent malaria — a parasitic infection spread by mosquitoes — in both adults and children. Second, it helps manage autoimmune cond...
  • What exactly is hydroxychloroquine used for?
  • Always take it by mouth with food or milk — this helps protect your stomach and reduces nausea. Don't crush or split the tablet unless your specific product allows it; check your l...
  • How should I take my hydroxychloroquine tablet?
📖 Read our full Hydroxychloroquine guide →

🕸️ Concept Web — How Hydroxychloroquine sulfate 300 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Hydroxychloroquine sulfate 300 MG Oral Tablet RxCUI 2569283

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Hydroxychloroquine 5521
    • Hydroxychloroquine sulfate 153972
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Sovuna 2665276
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Hydroxychloroquine Oral Tablet 370656
    • Hydroxychloroquine sulfate Oral Tablet 2649121
    • Hydroxychloroquine Oral Product 1164627
    • Hydroxychloroquine Pill 1164628
    • Hydroxychloroquine sulfate Oral Product 2661735
    • Hydroxychloroquine sulfate Pill 2662514
    • Hydroxychloroquine Oral Tablet [Sovuna] 2665280
    • Hydroxychloroquine sulfate Oral Tablet [Sovuna] 2665281
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Hydroxychloroquine sulfate 300 MG SCDC · 2569282
  • Hydroxychloroquine Oral Tablet SCDF · 370656
  • Hydroxychloroquine sulfate Oral Tablet SCDFP · 2649121
  • Hydroxychloroquine Oral Product SCDG · 1164627
  • Hydroxychloroquine Pill SCDG · 1164628
  • Hydroxychloroquine sulfate Oral Product SCDGP · 2661735
  • Hydroxychloroquine sulfate Pill SCDGP · 2662514

Brand-Name Concepts

  • Hydroxychloroquine sulfate 300 MG Oral Tablet [Sovuna] SBD · 2665284
  • Hydroxychloroquine sulfate 300 MG [Sovuna] SBDC · 2665283
  • Hydroxychloroquine Oral Tablet [Sovuna] SBDF · 2665280
  • Hydroxychloroquine sulfate Oral Tablet [Sovuna] SBDFP · 2665281
  • Sovuna Oral Product SBDG · 2665278
  • Sovuna Pill SBDG · 2665279
  • Sovuna BN · 2665276

📦 FDA Products & Package NDCs

11 products · 20 package NDCs
20 package NDCs map to RxCUI 2569283 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
16729-0485-01 100 TABLET in 1 BOTTLE (16729-485-01) Hydroxychloroquine Sulfate Accord Healthcare, Inc., 2021-01-26
16729-0485-16 500 TABLET in 1 BOTTLE (16729-485-16) Hydroxychloroquine Sulfate Accord Healthcare, Inc., 2020-05-12
16729-0561-01 100 TABLET in 1 BOTTLE (16729-561-01) Hydroxychloroquine Sulfate Accord Healthcare, Inc., 2021-09-28
16729-0562-01 100 TABLET in 1 BOTTLE (16729-562-01) Hydroxychloroquine Sulfate Accord Healthcare, Inc., 2021-09-28
16729-0563-01 100 TABLET in 1 BOTTLE (16729-563-01) Hydroxychloroquine Sulfate Accord Healthcare, Inc., 2021-09-28
43598-0131-01 100 TABLET, FILM COATED in 1 BOTTLE (43598-131-01) HYDROXYCHLOROQUINE SULFATE Dr. Reddy's Laboratories Inc. 2022-10-24
43598-0131-05 500 TABLET, FILM COATED in 1 BOTTLE (43598-131-05) HYDROXYCHLOROQUINE SULFATE Dr. Reddy's Laboratories Inc. 2022-10-24
43598-0132-01 100 TABLET, FILM COATED in 1 BOTTLE (43598-132-01) HYDROXYCHLOROQUINE SULFATE Dr. Reddy's Laboratories Inc. 2022-10-24
43598-0132-05 500 TABLET, FILM COATED in 1 BOTTLE (43598-132-05) HYDROXYCHLOROQUINE SULFATE Dr. Reddy's Laboratories Inc. 2022-10-24
43598-0133-01 100 TABLET, FILM COATED in 1 BOTTLE (43598-133-01) HYDROXYCHLOROQUINE SULFATE Dr. Reddy's Laboratories Inc. 2022-10-24
43598-0133-05 500 TABLET, FILM COATED in 1 BOTTLE (43598-133-05) HYDROXYCHLOROQUINE SULFATE Dr. Reddy's Laboratories Inc. 2022-10-24
43598-0721-01 100 TABLET, FILM COATED in 1 BOTTLE (43598-721-01) HYDROXYCHLOROQUINE SULFATE Dr. Reddy's Laboratories Inc. 2018-05-01
43598-0721-05 500 TABLET, FILM COATED in 1 BOTTLE (43598-721-05) HYDROXYCHLOROQUINE SULFATE Dr. Reddy's Laboratories Inc. 2018-05-01
63629-4465-01 30 TABLET in 1 BOTTLE (63629-4465-1) HYDROXYCHLOROQUINE SULFATE Bryant Ranch Prepack 2024-08-16
63629-4465-02 14 TABLET in 1 BOTTLE (63629-4465-2) HYDROXYCHLOROQUINE SULFATE Bryant Ranch Prepack 2024-08-16
70954-0804-10 30 TABLET, FILM COATED in 1 BOTTLE (70954-804-10) SOVUNA ANI Pharmaceuticals, Inc. 2023-09-15
70954-0804-20 100 TABLET, FILM COATED in 1 BOTTLE (70954-804-20) SOVUNA ANI Pharmaceuticals, Inc. 2023-09-15
70954-0804-30 14 TABLET, FILM COATED in 1 BOTTLE (70954-804-30) SOVUNA ANI Pharmaceuticals, Inc. 2023-09-15
70954-0805-10 100 TABLET, FILM COATED in 1 BOTTLE (70954-805-10) SOVUNA ANI Pharmaceuticals, Inc. 2023-09-15
70954-0805-20 14 TABLET, FILM COATED in 1 BOTTLE (70954-805-20) SOVUNA ANI Pharmaceuticals, Inc. 2023-09-15
Observed labelers: Dr. Reddy's Laboratories Inc. (8) · Accord Healthcare, Inc., (5) · ANI Pharmaceuticals, Inc. (5) · Bryant Ranch Prepack (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.